Allan Lipton

1.6k total citations · 1 hit paper
10 papers, 1.2k citations indexed

About

Allan Lipton is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Allan Lipton has authored 10 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Allan Lipton's work include Radiopharmaceutical Chemistry and Applications (3 papers), Bone health and treatments (3 papers) and Estrogen and related hormone effects (2 papers). Allan Lipton is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (3 papers), Bone health and treatments (3 papers) and Estrogen and related hormone effects (2 papers). Allan Lipton collaborates with scholars based in United States, Switzerland and France. Allan Lipton's co-authors include John J. Seaman, Joseph F. Simeone, Dirk J. Reitsma, Gabriel N. Hortobagyi, Robert E. Coleman, Lee S. Rosen, Robert Dreicer, Lester Porter, Anthony Howell and Steven A. Kuross and has published in prestigious journals such as Cancer, Breast Cancer Research and Treatment and Calcified Tissue International.

In The Last Decade

Allan Lipton

10 papers receiving 1.1k citations

Hit Papers

Pamidronate prevents skeletal complications and is effect... 2000 2026 2008 2017 2000 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases
    2000 505 citations Allan Lipton, Gabriel N. Hortobagyi et al. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Allan Lipton United States 9 1000 434 249 214 197 10 1.2k
J.J. Body Belgium 20 1.0k 1.0× 372 0.9× 267 1.1× 202 0.9× 551 2.8× 47 1.4k
G. Gorzegno Italy 21 836 0.8× 251 0.6× 440 1.8× 182 0.9× 99 0.5× 51 1.4k
L.V.A.M. Beex Netherlands 14 573 0.6× 153 0.4× 177 0.7× 118 0.6× 67 0.3× 33 844
Blair Egerdie Canada 15 916 0.9× 257 0.6× 712 2.9× 243 1.1× 407 2.1× 31 1.7k
P. Venner Canada 6 1.1k 1.1× 520 1.2× 887 3.6× 237 1.1× 209 1.1× 12 1.3k
A. Galid Austria 9 519 0.5× 155 0.4× 167 0.7× 65 0.3× 113 0.6× 27 748
T. Taube Finland 12 515 0.5× 201 0.5× 162 0.7× 87 0.4× 119 0.6× 15 620
Jamal Zekri Saudi Arabia 14 653 0.7× 174 0.4× 367 1.5× 118 0.6× 68 0.3× 68 945
Bijvoet Ol Netherlands 10 515 0.5× 128 0.3× 150 0.6× 50 0.2× 266 1.4× 17 720
Annalisa La Cesa Italy 14 459 0.5× 117 0.3× 142 0.6× 67 0.3× 142 0.7× 24 657

Countries citing papers authored by Allan Lipton

Since Specialization
Citations

This map shows the geographic impact of Allan Lipton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan Lipton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan Lipton more than expected).

Fields of papers citing papers by Allan Lipton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan Lipton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan Lipton. The network helps show where Allan Lipton may publish in the future.

Co-authorship network of co-authors of Allan Lipton

This figure shows the co-authorship network connecting the top 25 collaborators of Allan Lipton. A scholar is included among the top collaborators of Allan Lipton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allan Lipton. Allan Lipton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Gineyts, Évelyne, Nicolas Bonnet, C. Bertholon, et al.. (2018). The C-Terminal Intact Forms of Periostin (iPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone Metastasis. Calcified Tissue International. 103(5). 567–580. 9 indexed citations
2.
Rosen, Lee S., Anthony Howell, Lester Porter, et al.. (2001). Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases. Cancer. 91(7). 1191–1200. 398 indexed citations
3.
Lipton, Allan, et al.. (2000). Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases. Cancer. 88(5). 1082–1090. 505 indexed citations breakdown →
4.
Lipton, Allan & James R. Berenson. (1999). Bisphosphonate Treatment of Lytic Bone Metastases. Drugs & Aging. 14(4). 241–246. 8 indexed citations
5.
Witters, Lois, Rakesh Kumar, Vernon M. Chinchilli, & Allan Lipton. (1997). Enhanced anti-proliferative activity of the combination of tamoxifen plus HER-2-neu antibody. Breast Cancer Research and Treatment. 42(1). 1–5. 78 indexed citations
6.
Leitzel, Kim, et al.. (1996). Serial serum c-erbB-2 levels in patients with breast carcinoma. Cancer. 78(2). 267–272. 44 indexed citations
7.
Masamura, Shigeru, Herman Adlercreutz, Harold A. Harvey, et al.. (1995). Aromatase inhibitor development for treatment of breast cancer. Breast Cancer Research and Treatment. 33(1). 19–26. 28 indexed citations
8.
Lipton, Allan, et al.. (1990). A phase I trial of CGS 16949a. A new aromatase inhibitor. Cancer. 65(6). 1279–1285. 59 indexed citations
9.
Manni, Andrea, Alice E. Boucher, L. M. Demers, et al.. (1989). Endocrine effects of combined somatostatin analog and bromocriptine therapy in women with advanced breast cancer. Breast Cancer Research and Treatment. 14(3). 289–298. 56 indexed citations
10.
Manni, Andrea, Alice E. Boucher, Allan Lipton, et al.. (1987). Androgen depletion and repletion as a means of potentiating the effect of cytotoxic chemotherapy in advanced prostate cancer. Journal of Steroid Biochemistry. 27(1-3). 551–556. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.J. Body Breakdown of academic impact, for papers by G. Gorzegno Breakdown of academic impact, for papers by L.V.A.M. Beex Breakdown of academic impact, for papers by Blair Egerdie Breakdown of academic impact, for papers by P. Venner Breakdown of academic impact, for papers by A. Galid Breakdown of academic impact, for papers by T. Taube Breakdown of academic impact, for papers by Jamal Zekri Breakdown of academic impact, for papers by Bijvoet Ol Breakdown of academic impact, for papers by Annalisa La Cesa
Rankless by CCL
2026